Abstract
RA-UIP has a poor prognosis, and how to reverse or stabilize the lesions
remains challenging. Based on researches finding that tofacitinib and
IGU might be effective in pulmonary fibrosis, we present 3 cases of
RA-UIP that treated with the combined strategy with significant
improvement of DAS28-CRP score and reversals in chest HRCT assessment.
Keywords: Rheumatoid arthritis-related usual interstitial
pneumonia; Combination therapy; Dual treat-to-target, Case report.